Foundation for Taxpayer and Consumer Rights Supports Lee-Halpern Petition
By Jerry Flanagan
| 02. 16. 2005
Robert Klein
Chair
Independent Citizen's Oversight Committee
Mr. Klein,
The eyes of the world are on California. New medical treatments and funding strategies developed in the world's sixth leading economy will become national models. The success or failure of the California experiment could decide the fate of stem cell research for years to come.
We are writing to express our deep concern with the failure of the California Institute for Regenerative Medicine ("CIRM") and Independent Citizen's Oversight Committee ("ICOC") to guarantee an open, democratic decision-making process and disregard of state conflict of interest laws. The Foundation for Taxpayer and Consumer Rights (FTCR) calls on the CIRM and ICOC to support the petition filed by Philip R. Lee, MD, and Charles Halpern, JD.
When voters approved the unprecedented $3 billion in taxpayer-funded bonds to support stem cell research, they did so to provide access to innovative medical technologies for all Californians. However, the public availability of new medical technologies is threatened by a web of conflicts between those responsible for awarding research grants and the biotech and pharmaceutical companies who stand...
Related Articles
By Brittany Luse, Corey Antonio Rose, Neena Pathak, NPR | 02.27.2026
Who gets to be "hot" in America? And, at what cost?
Some young men are pushing beauty boundaries with guidance from an online trend that's been making headlines: looksmaxxing. Looksmaxxing celebrates intense fitness & skincare routines, extreme body modification, and...
By Kiana Jackson and Shannon Stubblefield, New Disabled South | 02.09.2026
"MC0_8230" via Wikimedia Commons licensed under CC by 2.0
This report documents a deliberate assault on disabled people in the United States. Not an accident. Not a series of bureaucratic missteps. An assault that has been coordinated across agencies...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Ava Kofman, The New Yorker | 02.09.2026
1. The Surrogates
In the delicate jargon of the fertility industry, a woman who carries a child for someone else is said to be going on a “journey.” Kayla Elliott began hers in February, 2024, not long after she posted...